Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgery | 3 | 2024 | 44 | 1.210 |
Why?
|
| Spinal Fusion | 8 | 2022 | 254 | 0.950 |
Why?
|
| Cervical Vertebrae | 4 | 2022 | 145 | 0.830 |
Why?
|
| Internal Fixators | 2 | 2021 | 36 | 0.700 |
Why?
|
| Skull Base | 1 | 2020 | 54 | 0.650 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 94 | 0.630 |
Why?
|
| Students, Medical | 1 | 2024 | 364 | 0.610 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 250 | 0.420 |
Why?
|
| Meningioma | 2 | 2023 | 95 | 0.380 |
Why?
|
| Meningeal Neoplasms | 2 | 2023 | 103 | 0.370 |
Why?
|
| Postoperative Complications | 5 | 2022 | 2797 | 0.360 |
Why?
|
| Radiculopathy | 2 | 2022 | 39 | 0.340 |
Why?
|
| Spinal Cord Diseases | 2 | 2021 | 44 | 0.330 |
Why?
|
| Glioma | 2 | 2025 | 427 | 0.300 |
Why?
|
| Brain Neoplasms | 3 | 2025 | 1304 | 0.280 |
Why?
|
| Lumbosacral Region | 3 | 2022 | 62 | 0.260 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2018 | 170 | 0.250 |
Why?
|
| Dexamethasone | 2 | 2018 | 380 | 0.230 |
Why?
|
| Treatment Outcome | 11 | 2025 | 11120 | 0.220 |
Why?
|
| Synovial Cyst | 1 | 2022 | 5 | 0.200 |
Why?
|
| Neurosurgical Procedures | 2 | 2023 | 208 | 0.200 |
Why?
|
| Chyle | 1 | 2022 | 4 | 0.200 |
Why?
|
| Opiate Alkaloids | 1 | 2022 | 7 | 0.200 |
Why?
|
| Spheroids, Cellular | 3 | 2018 | 77 | 0.190 |
Why?
|
| Pseudarthrosis | 1 | 2022 | 14 | 0.190 |
Why?
|
| Cell Movement | 2 | 2017 | 990 | 0.190 |
Why?
|
| Spinal Diseases | 1 | 2022 | 51 | 0.180 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2022 | 41 | 0.180 |
Why?
|
| Hernia | 1 | 2021 | 11 | 0.180 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2021 | 34 | 0.170 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2020 | 19 | 0.170 |
Why?
|
| Atlanto-Axial Joint | 1 | 2020 | 13 | 0.170 |
Why?
|
| Herniorrhaphy | 1 | 2021 | 76 | 0.170 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cavernous Sinus | 1 | 2020 | 20 | 0.170 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 32 | 0.160 |
Why?
|
| Myotomy | 1 | 2020 | 15 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2019 | 114 | 0.150 |
Why?
|
| Bone Screws | 1 | 2020 | 105 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 273 | 0.150 |
Why?
|
| Radial Artery | 1 | 2019 | 69 | 0.150 |
Why?
|
| Machine Learning | 1 | 2025 | 553 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2020 | 108 | 0.150 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 78 | 0.150 |
Why?
|
| Spinal Cord Compression | 1 | 2018 | 21 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 98 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2024 | 1202 | 0.150 |
Why?
|
| Spinal Neoplasms | 1 | 2018 | 36 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 2018 | 25 | 0.140 |
Why?
|
| Humans | 26 | 2025 | 141187 | 0.140 |
Why?
|
| Retrospective Studies | 11 | 2023 | 16273 | 0.140 |
Why?
|
| Joint Instability | 1 | 2020 | 168 | 0.140 |
Why?
|
| Calreticulin | 1 | 2018 | 28 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 148 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2020 | 554 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 241 | 0.140 |
Why?
|
| Surgeons | 1 | 2022 | 335 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 85 | 0.130 |
Why?
|
| Diphenylamine | 1 | 2017 | 9 | 0.130 |
Why?
|
| Glioblastoma | 2 | 2018 | 347 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 750 | 0.130 |
Why?
|
| Disease Management | 1 | 2021 | 633 | 0.130 |
Why?
|
| Neuroglia | 1 | 2017 | 173 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 175 | 0.120 |
Why?
|
| Internship and Residency | 2 | 2024 | 1235 | 0.120 |
Why?
|
| Disease Progression | 2 | 2021 | 2793 | 0.120 |
Why?
|
| Benzamides | 1 | 2017 | 216 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 355 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2018 | 392 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 562 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2504 | 0.100 |
Why?
|
| Female | 9 | 2025 | 75515 | 0.100 |
Why?
|
| Decompression, Surgical | 2 | 2022 | 113 | 0.090 |
Why?
|
| Diskectomy | 2 | 2022 | 25 | 0.090 |
Why?
|
| Adult | 6 | 2024 | 39177 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5929 | 0.090 |
Why?
|
| Middle Aged | 6 | 2023 | 34434 | 0.080 |
Why?
|
| Operating Rooms | 2 | 2023 | 146 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2746 | 0.080 |
Why?
|
| Male | 7 | 2025 | 69783 | 0.070 |
Why?
|
| Prognosis | 2 | 2025 | 4073 | 0.060 |
Why?
|
| Retina | 2 | 2018 | 314 | 0.060 |
Why?
|
| Superior Sagittal Sinus | 1 | 2023 | 4 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2025 | 316 | 0.050 |
Why?
|
| Laminectomy | 1 | 2022 | 32 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 111 | 0.050 |
Why?
|
| Unsupervised Machine Learning | 1 | 2022 | 23 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 172 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 222 | 0.040 |
Why?
|
| Cranial Sinuses | 1 | 2020 | 14 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2022 | 179 | 0.040 |
Why?
|
| Pharyngeal Muscles | 1 | 2020 | 5 | 0.040 |
Why?
|
| Spine | 1 | 2022 | 180 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 129 | 0.040 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 17 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2025 | 640 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 194 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 93 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 309 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 299 | 0.040 |
Why?
|
| Catheterization | 1 | 2020 | 182 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 154 | 0.040 |
Why?
|
| Microsurgery | 1 | 2019 | 77 | 0.040 |
Why?
|
| Reoperation | 1 | 2021 | 588 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 433 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 318 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1003 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 339 | 0.040 |
Why?
|
| Feeder Cells | 1 | 2017 | 3 | 0.030 |
Why?
|
| Microtomy | 1 | 2017 | 5 | 0.030 |
Why?
|
| Aged | 3 | 2023 | 24574 | 0.030 |
Why?
|
| Patient Selection | 1 | 2021 | 688 | 0.030 |
Why?
|
| Fibronectins | 1 | 2018 | 135 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1073 | 0.030 |
Why?
|
| Pain | 1 | 2022 | 781 | 0.030 |
Why?
|
| Patient Safety | 1 | 2019 | 335 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2020 | 280 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 324 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 959 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 2794 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 2858 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2017 | 468 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 1018 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 961 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 806 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 2902 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 835 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 325 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 859 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 423 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 368 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 22007 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 1116 | 0.030 |
Why?
|
| Child | 2 | 2025 | 22308 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 555 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 2064 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 2885 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 1768 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5200 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 4174 | 0.020 |
Why?
|
| Models, Biological | 1 | 2018 | 1828 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5799 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 9818 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3709 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 18048 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 4208 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 11457 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3469 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 7739 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 13673 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 37657 | 0.010 |
Why?
|